Black Garlic and Inflammation: Mostly Mechanistic, Not a Treatment Claim

Inflammation is a broad biological process, and “anti-inflammatory” is often used too casually in supplement marketing.

What black-garlic laboratory studies examine

Researchers have isolated compounds from aged black garlic and tested them in immune-cell models. One study reported effects on inflammatory mediators and signalling pathways in cultured macrophage cells.

Why a cell study is not a clinical treatment

Cells in a laboratory can be exposed directly to a controlled concentration. A person swallowing black garlic has digestion, absorption, metabolism, tissue distribution and many other variables between the ingredient and a clinical outcome.

Human garlic studies also need preparation matching

Some trials of ordinary garlic extract report inflammatory biomarkers, but those results should not be relabelled as black-garlic evidence.

Biomarkers are not the same as disease outcomes

Even in humans, a change in a marker such as CRP does not automatically prove improvement in symptoms or prevention of a specific disease.

Responsible conclusion

Black garlic has interesting mechanistic research related to inflammatory pathways, but that evidence is not sufficient to present a generic supplement as a treatment for inflammatory disease.

Specific reference

• Aged black garlic compounds in a macrophage cell model. PMID 27686665.

Core black garlic references

• Mandge HM et al. Systematic review of black garlic phytochemistry and biofunctionality. PMID 41695811.
• Ahmed T, Wang CK. Black Garlic and Its Bioactive Compounds on Human Health Diseases: A Review. PMID 34443625.
• Moreno-Ortega A et al. Human bioavailability of organosulfur compounds after black garlic ingestion. PMID 37107300.

This article is educational, not medical advice. Do not use a food supplement to replace prescribed treatment.